Offer - Urjas Oil for just ₹ 1 X
Olvan Trio 20 Tablet, a prescription drug, is manufactured in various forms such as Tablet. The alternative uses of Olvan Trio 20 Tablet have also been explained below.
The right dosage of Olvan Trio 20 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Olvan Trio 20 Tablet include Upper respiratory tract infection, Loss of appetite, Gastric Irritation. Some other side effects of Olvan Trio 20 Tablet have been listed ahead. Usually, these side effects of Olvan Trio 20 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Olvan Trio 20 Tablet is Mild for pregnant women and Mild for women who are breastfeeding. Further, the section on Olvan Trio 20 Tablet related warnings talks about Olvan Trio 20 Tablet's effects on the liver, heart and kidney.
Olvan Trio 20 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) are examples of such conditions. Some other conditions that can be affected by Olvan Trio 20 Tablet are listed in the contraindications section below.
Drug interactions for Olvan Trio 20 Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Olvan Trio 20 Tablet is not safe while driving, and is is not addictive in nature.
Olvan Trio 20 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olvan Trio 20 Tablet safe for pregnant women?
Olvan Trio has mild to no side effects in pregnant women.
Is the use of Olvan Trio 20 Tablet safe during breastfeeding?
Olvan Trio has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olvan Trio 20 Tablet on the Kidneys?
Very few cases of side effects of Olvan Trio on kidney have been reported.
What is the effect of Olvan Trio 20 Tablet on the Liver?
Olvan Trio is rarely harmful for the liver.
What is the effect of Olvan Trio 20 Tablet on the Heart?
Olvan Trio is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Olvan Trio 20 Tablet unless your doctor advises you to do so -
Is this Olvan Trio 20 Tablet habit forming or addictive?
No, you will not get addicted to Olvan Trio 20 Tablet.
Interaction between Food and Olvan Trio 20 Tablet
Taking Olvan Trio 20 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olvan Trio 20 Tablet
Taking alcohol with Olvan Trio 20 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448